Skip To The Main Content
Parenteral Drug Association Connecting People, Science and Regulation ®

Press Releases

  • 04/23/2020

    PDA Forms Coronavirus Pandemic Response Task Force, New Advanced Therapy Advisory Board

    Bethesda, Md. – The Parenteral Drug Association, Inc. (PDA) today announced two new volunteer opportunities and changes to its Board of Directors/Executive Committee following its spring Board of Directors meeting.
  • 04/17/2020

    PDA Announces Availability of ANSI/PDA Standard 001-2020 on Purchasing Controls

    Bethesda, Md. – The Parenteral Drug Association (PDA) today announced the availability of ANSI/PDA Standard 001-2020, Enhanced Purchasing Controls to Support the Bio-Pharmaceutical, Pharmaceutical, Medical Devices, and Combination Products Industries, which was approved by the ANSI Board of Standards Review on March 13, 2020.
  • 04/07/2020

    Parenteral Drug Association Announces its 2020 – 2026 Strategic Plan

    Bethesda, Md. – The Parenteral Drug Association, Inc. (PDA) today announced the availability of its 2020 – 2026 Strategic Plan, which was developed to assist PDA in achieving its vision to be the premier global leader in advancing bio/pharmaceutical manufacturing, science, technology, and regulation to enable members to better serve patients. The plan was developed by PDA’s Strategic Planning Committee at the direction of the PDA Board of Directors.
  • 03/27/2020

    Parenteral Drug Association Announces Measures to Support Pharma/Biopharma Industries during Covid-19 Pandemic

    Bethesda, Md. – The Parenteral Drug Association (PDA) announced that it is suspending membership expirations retroactively to March 1 and continuing until the end of June. All members will continue to enjoy the benefits of membership, even if you are unable to pay due to the impact of the corona virus pandemic.
  • 03/10/2020

    PDA Names Former Eli Lilly Exec. Glenn E. Wright Vice President of Scientific and Regulatory Affairs Dr. Tina Morris is leaving PDA to become Executive Director at AAPS

    Bethesda, Md. – The Parenteral Drug Association (PDA) today announced the appointment of former Eli Lilly and Co. - Executive Glenn E. Wright as Vice President of Scientific and Regulatory Affairs, effective March 23. Mr. Wright most recently worked as Senior Director of Quality Operations at Exelead, a contract manufacturer. Mr. Wright also has worked for Amgen and Pfizer.
  • 02/12/2020

    PDA Europe Parenteral Packaging to Address EU MDR 117 and Closed Systems

    Berlin – Parenteral Drug Association Europe (PDA EU) is hosting its 10th Parenteral Packaging Conference in Basel, Switzerland, 25-26 February. The conference features presentations and discussions by industry leaders and technical experts from pharma and supplier companies. This year’s event includes expert discussions on the EU’s Medical Device Regulation 117 and on closed system transfer devices.
  • 02/05/2020

    PDA and AAMI Announce Plans to Explore Collaborations

    Bethesda, Md. – The Parenteral Drug Association (PDA) and the Association for the Advancement of Medical Instrumentation (AAMI) today announced their agreement to explore collaborations to further the missions of both organizations and enhance value to their members, stakeholders, and their respective communities at large. The two heads of each organization met at PDA’s headquarters on Jan. 29 to sign a collaboration agreement.
  • 01/28/2020

    PDA Announces 2020 United States Conference Schedule

    Bethesda, Md. – The Parenteral Drug Association (PDA) today announced its schedule of U.S. conferences for the year. The busy schedule includes PDA’s signature events and new “hot topic” workshops.